Schmidt K et al. |
Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. |
1999 |
Arch. Pharm. (Weinheim) |
pmid:10575368
|
Jung M et al. |
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. |
1999 |
J. Med. Chem. |
pmid:10579829
|
Chien PY et al. |
A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. |
1999 |
Mol. Endocrinol. |
pmid:10598586
|
Taddei A et al. |
Duplication and maintenance of heterochromatin domains. |
1999 |
J. Cell Biol. |
pmid:10601331
|
Marenzi S et al. |
Efficiency of expression of transfected genes depends on the cell cycle. |
1999 |
Mol. Biol. Rep. |
pmid:10634509
|
Gray SG et al. |
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells. |
1999 |
Exp. Cell Res. |
pmid:10585285
|
Saunders N et al. |
Histone deacetylase inhibitors as potential anti-skin cancer agents. |
1999 |
Cancer Res. |
pmid:9927053
|
Bakin AV and Curran T |
Role of DNA 5-methylcytosine transferase in cell transformation by fos. |
1999 |
Science |
pmid:9888853
|
Murphy M et al. |
Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. |
1999 |
Genes Dev. |
pmid:10521394
|
Gobl AE et al. |
Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. |
1999 |
Biochim. Biophys. Acta |
pmid:10500243
|
Kosugi H et al. |
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. |
1999 |
Leukemia |
pmid:10482980
|
Carmen AA et al. |
Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10535926
|
Rüller S et al. |
Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy. |
1999 |
Clin. Cancer Res. |
pmid:10537334
|
Vanden Berghe W et al. |
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. |
1999 |
J. Biol. Chem. |
pmid:10542243
|
Ng HH et al. |
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. |
1999 |
Nat. Genet. |
pmid:10471499
|
Fukuda K |
Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. |
1999 Mar-Apr |
Int. J. Biochem. Cell Biol. |
pmid:10224675
|
Chen WY and Townes TM |
Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. |
2000 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10618426
|
Xiao H et al. |
p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. |
2000 |
J. Biol. Chem. |
pmid:10625687
|
Cong YS and Bacchetti S |
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. |
2000 |
J. Biol. Chem. |
pmid:10986277
|
Wei LN et al. |
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. |
2000 |
J. Biol. Chem. |
pmid:11006275
|